Mutations in the gene encoding the type II transmembrane protease 3 (TMPRSS3) cause human hearing loss, although the underlying mechanisms that result in TMPRSS3-related hearing loss are still unclear. We combined the use of stem cell-derived inner ear organoids with single-cell RNA sequencing to investigate the role of TMPRSS3. Defective Tmprss3 leads to hair cell apoptosis without altering the development of hair cells and the formation of the mechanotransduction apparatus. Prior to degeneration, Tmprss3-KO hair cells demonstrate reduced numbers of BK channels and lower expressions of genes encoding calcium ion-binding proteins, suggesting a disruption in intracellular homeostasis. A proteolytically active TMPRSS3 was detected on cell membranes in addition to ER of cells in inner ear organoids. Our in vitro model recapitulated salient features of genetically associated inner ear abnormalities and will serve as a powerful tool for studying inner ear disorders.
INTRODUCTION
Auditory and vestibular systems share numerous molecular constituents, as well as a common molecular evolution, although these systems differ in their structure, cellular components, and physiological properties (Fritzsch and Straka, 2014; Gillespie and Muller, 2009) . Defects in the conserved features may consequently impair both hearing and balance (Keats and Corey, 1999; Shinjo et al., 2007; Zhou et al., 2009 ). One such family of molecules includes type II transmembrane serine proteases, which are classified by their N-terminal anchor to membranes and contain an active C-terminal serine protease domain (Barre et al., 2014; Szabo and Bugge, 2011) . One such type II transmembrane serine protease, TMPRSS3, is required for proper mammalian hearing, and mutations in TMPRSS3 cause congenital and early-onset hearing loss (Scott et al., 2001) . Indeed, large-scale sequencing projects investigating the genetic etiology of deafness revealed that $9% of genetic-associated hearing loss cases are due to mutations in TMPRSS3 (Bademci et al., 2016; Sloan-Heggen et al., 2016) .
Our current understanding of the role of TMPRSS3 in the pathobiology of deafness comes from studies on mice harboring a nonsense mutation in Tmprss3 (Tmprss3  Y260X ) , which results in a truncated protease domain (Fasquelle et al., 2011) . These mice display normal cochlear and vestibular hair cells (HCs) in the early postnatal period followed by rapid cochlear HC degeneration starting on postnatal day 12 (P12) (Fasquelle et al., 2011) . In addition, Tmprss3 mutant mice display saccular abnormalities as well as aberrant vestibular function (Fasquelle et al., 2011) . Despite these observations, the cellular function of TMPRSS3 and the mechanisms underlying HC degeneration have yet to be elucidated. Previously, TMPRSS3 was implicated in regulating both epithelial sodium channels (ENaC [Guipponi et al., 2002] ) and potassium calcium-activated channel subfamily M alpha 1 (KCNMA1 [Molina et al., 2013] ). However, pseudohypoaldosteronism type I patients with defective ENaC in the cochlea have normal hearing (Peters et al., 2006) . This suggests that while TMPRSS3 might contribute to ENaC regulation, TMPRSS3-mediated ENaC dysfunction is not the primary mechanism underlying auditory and vestibular dysfunction.
In recent years, organoid cultures have gained acceptance as in vitro models of various organ systems. They offer the advantages of scalability, accessibility, and the capacity for rapid and precise genetic manipulation in the laboratory. To better understand the defective Tmprss3-implicated HC degeneration, we capitalized on the stem cell-derived three-dimensional inner ear organoid system (Koehler et al., 2013; Liu et al., 2016) , which features HCs characterized by the same structural and functional properties of vestibular HCs. Upon using this system, Tmprss3 mutations resulted in HC apoptosis in both mouse vestibular sensory epithelia (in vivo) and inner ear organoids (in vitro); such congruency signifies that stem cell-derived inner ear organoids can recapitulate gene mutation-associated pathological features in vivo. The level of HC degeneration was dependent on the nature of the mutation (and consequently the structure of the resulting TMPRSS3 protein). Furthermore, we also revealed a previously undocumented subcellular localization of TMPRSS3. In combination with singlecell RNA sequencing (scRNA-seq) data, we propose (legend continued on next page) several potential roles of TMPRSS3 in HC degeneration. These findings highlight the unique advantages in using organoid systems to model disease mechanisms and have improved our understanding of the role of TMPRSS3 in the inner ear.
RESULTS

TMPRSS3 Protease Activity Is Not Required for Proper Inner Ear Organoid Development
To establish the stem cell-derived inner ear organoid model of Tmprss3 dysfunction, we began by comparing the pathological effects of Tmprss3 mutations in HCs between a previously generated mouse model (Fasquelle et al., 2011) and inner ear organoids. Tmprss3 mutant mice (Tmprss3  Y260X ) carrying a nonsense mutation, which results in a truncated protease domain ( Figure 1A ), were used as the in vivo counterparts. We derived mouse embryonic stem cell (mESC) lines from both wild-type (WT; Tmprss3
WT
) and mutant Tmprss3 Y260X mice on the same C3HeB/FeJ background strain ( Figure 1A ). After characterization, we selected a WT (C3H-WT) and a mutant (C3H-Y260X) cell line, and the pluripotency of these mESC lines were verified using three pluripotency markers: OCT3/4, NANOG, and SOX2 ( Figure S1 ). Inner ear organoids were derived from both C3H-WT and C3H-Y260X, and the development of organoids was checked with specific molecular markers at three key time points ( Figure 1B ) based on the previous study by Koehler et al. (2013) (Fasquelle et al., 2011) . According to electrophysiological data, organoid HCs showed developmental patterns (with respect to timing and physiology) similar to those of mice, and HCs on culture days 22-27 demonstrated comparable mechanosensitivity to P2-P5 mouse utricle HCs . In this study we extended the culture period to 40 days, which allowed for the growth of HCs that were equivalent to those of P12-P14 mice. We analyzed the sensory epithelia for signs of HC degeneration both in vivo and in vitro. Consistent with the previous study (Fasquelle et al., 2011) , we observed the loss of HCs in Tmprss3 Y260X cochlea by P14 ( Figure S2 Next, we examined mESC-derived organoids from these mice for signs of apoptosis and HC degeneration. Otic vesicles in both C3H-WT and C3H-Y260X organoids on D28 and D33 were characterized by indistinguishable levels of CASP3 ( Figure S3 ). However, by D38, significantly elevated CASP3 levels were detected in the sensory epithelia of C3H-Y260X versus C3H-WT (p < 0.05; . A similar level of increase in CASP3 ($45%) was measured in otic vesicles and in mouse sensory epithelia (Figure 2 ). In summary, defective TMPRSS3 with truncated protease domains lead to elevated apoptotic signals in sensory epithelia in both mouse and inner ear organoids at similar stages (P14 versus D38, respectively).
Tmprss3 Knockout Inner Ear Organoids Undergo Normal Early Development
In humans, different mutations in TMPRSS3 lead to variable phenotypes (Lee et al., 2003; Weegerink et al., 2011) . We sought to determine the effect of complete loss of (I and J) Representative images of MYO7A + HCs with F-ACTIN-based hair bundles (HB) in D25 organoids. (C) to (J) show otic vesicles (n = 15) from three independent experiments. Other abbreviations: TM, transmembrane; LDLa, low-density lipoprotein a; SRCR, scavenger receptor cysteine-rich; NNE, non-neural ectoderm; PPE, pre-placodal ectoderm; TGFb, transforming growth factor b; BMP4, bone morphogenetic protein 4; FGF, fibroblast growth factor . Scale bars, 50 mm (C-H) and 10 mm (I and J). See also Figures S1 and S7.
TMPRSS3 on HC development and survival. Furthermore, due to the lack of a specific TMPRSS3 antibody, the presence and localization of TMPRSS3 among inner ear cell types is unclear. To eliminate TMPRSS3 synthesis and observe gene expression under the endogenous Tmprss3 promoter, we generated a Tmprss3-knockout (KO)/nGFPknockin cell line using the commercially available mESC line R1/E. By using this second ESC line, we sought to verify whether the phenomena associated with Tmprss3 mutations are comparable across cell lines.
Previously, two Tmprss3 transcript variants (a and f) were reported (Fasquelle et al., 2011) . To knock out both transcripts and also create a Tmprss3 reporter, we inserted a nuclearly localized GFP (2A-nGFP) cassette with a stop codon in-frame into exon 2 of Tmprss3 ( Figure 3A) ; this resulted in 2A-nGFP being transcribed by the endogenous Tmprss3 promoter ( Figure 3A ). Correct biallelic insertion of the 2A-nGFP cassette in the mESC Tmprss3 locus was confirmed by PCR and DNA sequencing (Figures 3B and 3C; Supplemental Information) . No off-target indel was found based on DNA sequencing (Table S1) , and the pluripotency of the modified mESCs (named ''Tmprss3KO-GFPKI'') was verified with pluripotency markers ( Figures  3D-3F ). The early development of inner ear organoids in Tmprss3KO-GFPKI (KO) was examined at three key time points: D8, D14, and D21 ( Figure 1B) 
Degeneration of Hair Cells in D38 Tmprss3-KO Inner Ear Organoids
We next examined whether the loss of TMPRSS3 leads to HC degeneration. Along with GFP and CASP3 staining, HCs were labeled with the HC marker calretinin, and the structure of the sensory epithelia was examined by two conventional SC markers, SOX2 and SOX9 (Mak et al., 2009; Oesterle et al., 2008) . On D28 and D33, the structure of the otic vesicles, the integrity of the HCs, and the lack of CASP3 labeling on HCs all pointed to an absence of HC degeneration in both R1/E (WT) and , S4C, and S4D). Because disrupted otic vesicles were documented frequently in D38 KO organoids, such structural aberrancies hindered the measurement of CASP3 fluorescence intensity in sensory epithelia and led to highly variable labeling data. Therefore, western blots were used to quantify the difference in CASP3 levels between D36 WT and KO organoids ( Figures 4G and 4H) . A 3-fold increase in CASP3 levels (normalized to b-ACTIN concentrations) was detected in D36 KO organoids compared with D36 WT organoids (p < 0.001; Figure 4H ).
We also investigated the effects of (Dworetzky et al., 1994; Langer et al., 2003) , in cochlear HCs of Tmprss3 Y260X mice (Molina et al., 2013) . Since BK channels have also been documented in the vestibular HCs of mammals (Kong et al., 2005; Schweizer et al., 2009) , we sought to document whether the lack of TMPRSS3 also reduces the abundance of BK channels in the HCs of inner ear organoids. To avoid the effects caused by apoptosis, rather than the lack of TMPRSS3, the levels of BK channels were compared in R1/E (WT) and Tmprss3KO-GFPKI (KO) organoids on D33. BK channels were detected in 66% of all HCs (marked by MYO7A and BRN3C staining) in WT otic vesicles ( Figures 5A, 5B , and 5E), whereas a significantly lower percentage ($45%) was observed in D33 KO organoids (p < 0.001; Figures 5C-5E ).
Gene Expression Profiles of Inner Ear Organoids in R1/ E and Tmprss3KO-GFPKI Next, to elucidate the molecular mechanisms underlying Tmprss3 KO-caused HC degeneration, we carried out scRNA-seq. We profiled dissociated cells from R1/E (WT) and Tmprss3KO-GFPKI (KO) organoids at D25 and D35 using droplet microfluidics (103 Genomics Chromium) to obtain cell-barcoded cDNAs that were sequenced. We acquired high-quality reads from $8,000-10,000 cells from both WT and KO across 10-12 inner ear organoids.
We performed unsupervised cell clustering using t-distributed stochastic neighbor embedding (tSNE). Putative HC clusters were established based on conventional HC markers, such as TMC1, Myo7a, Pvalb, and Otof ( Figures  6A, 6C , and S5A-S5E). Expression of marker genes from neurons, oligodendrocytes, and epithelial cells was also observed in other clusters ( Figure S5 ).
In both D25 WT and KO organoids, putative HC clusters constituted 2% of all cells (Figures S5A and S5B ; Table S2 ). Although the percentage of cells in the putative HC cluster decreased to 1.24% in D35 WT organoids, this percentage was nevertheless 2-fold higher than in the KO (0.67%) at this time (Table S2 ). Integrated comparative analyses of WT and KO were performed with D25 and D35 samples ( Figures 6A, S5E, and S5F) , and the ratio of KO/WT in the D35 HC cluster (0.58) was lower than for D25 (0.76). This finding is depicted graphically in Figure 6B and suggests that the HC number decreased at D35 in KO organoids as a result of Tmprss3-KO.
Statistically over-representation tests were performed using genes detected in putative HC clusters among the four samples. Although overall HC gene assembly did not differ between WT and KO samples from the same culture day, more genes involved in developmental processes were documented at the earlier sampling time (Table S3 ). We also observed more genes associated with mature HCs (e.g., Kcna1, Calb2, and Tmc1 [Scheffer et al., 2015] ) in D35 organoids. These data consequently shed light on inner ear organoid development.
To unravel the mechanisms underlying the HC degeneration that was observed in later cultures, we examined differences in average gene expression between D35 WT and D35 KO organoids ( Figure 6D and Table S4 ). Less than 1% of all detected genes in the putative HC cluster were differentially expressed (41 differentially expressed genes [DEGs]; Table S4 ). There were 22 genes upregulated in the KO (KO-enriched) and 19 genes downregulated in the KO (KO-reduced). Integrated pathway analysis (IPA) of the KO-enriched genes linked to apoptosis while the KO-reduced genes did not link to a definitive pathway (Figures S5G and S5H) . We also performed function clustering analyses on all DEGs, but no specific pathway or biological process was identified.
From protein-protein interaction analyses, we found that six DEGs (15%) were previously documented to interact with KCNMA1 in mouse cochlea (Kathiresan et al., 2009) , and 16 DEGs (39%) encoding proteins interacting with 14-3-3-EPSILON ( Figure 6D ). Five of KO-reduced genes encode Ca 2+ -binding proteins ( Figure 6D ). Also, a KOreduced gene, Sln, encodes sarcolipin, which is a known Ca 2+ regulator in muscle. On the other hand, 12 of the 22 KO-enriched genes encoded proteins that associated with the extracellular matrix (ECM) ( Figure 6D ). Taken together, our results suggest that loss of TMPRSS3 may influence intracellular Ca 2+ homeostasis via its interaction with KCNMA1. Also, lack of TMPRSS3 might perturb the ECM in otic vesicles.
Cell Membrane Localization of TMPRSS3
To elucidate the subcellular localization of the TMPRSS3 protein, we constructed N-terminal-tagged 33FLAG (E) Dot plot of the percentage of HC with BK channels relative to the total number of HC in organoids (±SEM; n = 19 for WT otic vesicles and 24 for KO otic vesicles from three independent experiments; Student's t test, *p < 0.001).
Tmprss3f, and knocked in the construct to the ROSA 26 locus of R1/E (Figures 7A and S6A-S6E); this caused 33FLAG-Tmprss3f to be ubiquitously and constitutively expressed in all cells. Western blot with an anti-FLAG antibody presented a band at approximately 58-60 kDa in R1/EÀ33FLAG-Tmprss3f samples but not in R1/E samples ( Figure 7B ). In addition, the FLAG antibody recognized a 28-kDa band ( Figure 7B ), which is similar in size to an N-terminal fragment of 28.6 kDa after autocleavage at the predicted serine protease catalytic site of TMPRSS3F (Lee et al., 2003; Wattenhofer et al., 2005) .
During inner ear organoid induction, we noted nonnuclear staining corresponding to 33FLAG-TMPRSS3F that was punctate and overlapping with E-cadherin (ECAD), both localized to the plasma membrane in D14 aggregates ( Figures 7C-7D 0 ). Subsequently, we attempted to determine the localization of 33FLAG-TMPRSS3F in organoid HCs and found that it also labeled the cell membrane, as well as in the cytoplasm ( Figure S6F ). To improve resolution, we localized 33FLAG-TMPRSS3F on a monolayer of 33-FLAG-Tmprss3f ESCs, and further confirmed the localization on cell membranes via the co-localization of FLAG and phalloidin (F-ACTIN; Figure 7E ). TMPRSS3 was previously reported to localize to the ER (Guipponi et al., 2008) . Therefore, we examined whether 33FLAG-TMPRSS3F localizes to the ER using the ER marker CALRETICULIN, and observed partially overlapping staining ( Figure 7F ). We also noticed dense staining in the cytoplasm, potentially in/on the Golgi apparatus. Staining of Golgi-97 with an anti-FLAG antibody revealed overlapped staining ( Figure 7G ). Quantitative co-localization analyses indicated a positive correlation (Pearson's correlation) and complete co-localization (Van Steensel's cross-correlation functions plots) between FLAG and F-ACTIN signals ( Figure 7H ). On the other hand, Pearson's correlation coefficient (r) values for FLAG versus ER and FLAG versus the Golgi apparatus were 0.306 and 0.364, respectively; however, as the values were less than 0.5, complete positive co-localization was inconclusive. Overall, we showed proteolytic active TMPRSS3 localized on the cell membrane using transgenic mESC and inner ear organoid systems.
DISCUSSION
Our findings demonstrate that inner ear organoids recapitulate the in vivo development and pathology of HCs seen in mice (Tmprss3 Y260X ). FM1-43fx uptake assay, unlike electrophysiology that examines mechanotransduction function by deflecting HBs and measuring membrane potential changes, determines the existence of mechanotransduction apparatus based on the uptake of dye through channels within 10-15 s. The similar level of FM1-43fx uptake in both WT and Tmprss3-KO HCs, as well as the presence of intact tip link components, suggest that lack of TMPRSS3 does not impede the formation of the mechanotransduction apparatus as such, TMPRSS3 is not required for development nor early mechanotransduction, but rather is integral to HC survival. We found increased CASP3 signals in both sensory epithelia of Tmprss3 Y260X and C3H-Y260, as well as in organoids completely lacking TMPRSS3. The elevation of CASP3 suggests that HC death is a consequence of apoptosis. The anatomical integrity of HCs lacking TMPRSS3 protease activity differed from that of cells lacking the protein in its entirety. In D38 Tmprss3KO-GFPKI organoids HCs were difficult to identify, whereas D38 C3H-Y260X2 otic vesicles featured distinguishable HCs in the sensory epithelia. This suggests a genotype-phenotype correlation, which supports previous findings based on human genetic and patient data in which the phenotypes of individuals with Tmprss3 mutations vary widely according to genotype variants (Weegerink et al., 2011) . Loss of TMPRSS3-protease activity was previously reported to reduce cellular levels of KCNMA1 (the a subunits of the BK channel) in mouse cochlear HCs (Molina et al., 2013) . In this study, we observed a significant decrease in BK channels in KO HCs. Additionally, the reduced expression of several genes encoding Ca 2+ -binding proteins and intracellular Ca 2+ regulators in D35 KO HCs via scRNA-seq analyses might be a response to altered Ca 2+ homeostasis due to decreased BK channels. Furthermore, among D35 DEGs in the HC cluster, we identified six genes that encode proteins known to interact with KCNMA1 (Kathiresan et al., 2009 ). 14-3-3-EPSILON, Figure 6 . Comparison of Single-Cell Gene Expression Profiles between R1/E (WT) and Tmprss3KO-GFPKI (KO) Inner Ear Organoids (A) tSNE plot of D35 WT and D35 KO organoids after integrated comparative analyses. The red circle indicates the putative hair cell (HC) cluster.
(B) Top six cluster-defining genes for the putative HC clusters. Specifically, Calb2 and Kcna10 are postnatal HC markers (Scheffer et al., 2015) . Cells from D35 WT and D35 KO strongly expressing these markers contributing the putative HC cluster in (A) are shown. (C) HC markers used to identify the putative HC cluster.
(D) Analyses of difference in average gene expressions in the putative HC cluster between D35 WT and D35 KO. Genes encoding Ca 2+ -binding proteins (red), extracellular proteins (yellow), and proteins responding extracellular stimuli (blue) are indicated by color. Geneencoding proteins interacting with KCNMA1 and protein EPSILON are circled by red and green, respectively. See also Figure S5 .
which was reported to interact with multiple DEGs via protein-protein interaction analyses, was also known to be the putative protein-binding partner with BK channels and to affect its expression (Sokolowski et al., 2011) . Mice lacking 14-3-3 ETA (a family member of 14-3-3-EPSILON) exhibit cochlear HC degeneration via apoptosis (Buret et al., 2016) . Previous studies have demonstrated that inhibition of BK channels can cause cell apoptosis (Bortner and Cidlowski, 2014; Sakai and Sokolowski, 2015) . Although no biological pathways were significantly enriched upon analysis of the DEGs, genes involved in both apoptosis and cell survival were revealed after further exploring potential interactions using IPA (Figures S5G and S5H.) . Based on these data, one possible mechanism of HC loss is that defective TMPRSS3 leads to a decrease in BK channels via interactions with KCNMA1 with subsequent disruptions in intracellular Ca 2+ homeostasis, resulting thereafter in HC apoptosis. Differential gene expression analyses also showed that more than half of genes enriched in D35 KO HCs encode proteins that either regulate or structurally comprise ECM; this finding could be linked to the subcellular localization of TMPRSS3 on the cell surface. Although TMPRSS3 was only reported at ER previously (Guipponi et al., 2002 (Guipponi et al., , 2008 , it should be noted that cell membrane localization is more commonly reported for other members of the TMPRSS family (Brunati et al., 2015; Chen et al., 2010; Tsuji et al., 1991) . According to our data from scRNA-seq and 33FLAG-tagged TMPRSS3F we proposed that, in addition to effects on the Ca 2+ homeostasis, TMPRSS3 might also play roles in organization or regulation of ECM. Indeed, other members of the TMPRSS family have been shown to undertake multiple cellular functions in different cellular locations (Böttcher-Friebertshäuser et al., 2010 Chen et al., 2010) . Moreover, other yet to be identified protease substrates for TMPRSS3 are likely critical to the survival of HCs. For example, mutations in TMPRSS1 (also known as hepsin) also lead to hearing loss (Guipponi et al., 2007) . Mutations in hepatocyte growth factor (HGF), which is regulated by TMPRSS1 (Hsu et al., 2012) , cause deafness in humans (DFNB39) (Schultz et al., 2009) . Future studies exploring a similar functional interaction and other protease substrates of TMPRSS3 in the inner ear are of consequent need.
There are current limitations of stem cell-derived inner ear organoids. First, upon further optimizing previously published protocols (Koehler et al., 2013; Koehler and Hashino, 2014) , we extended the culture time from 30 to 45-50 days; however, organoid integrity became variable after D38, potentially due to the outgrowth of non-otic tissues. Therefore, D38 was chosen as the latest sampling time in this study to avoid any potential artifacts or degeneration arising from stress associated with longterm culture. Second, the protocol for inducing organoids varies across cell lines, and optimization for each cell line is necessary. Although both C3H-and R1/E-based lines gave rise to inner ear organoids after optimizing the protocol ( Figure S7 In summary, using a TMPRSS3 mutant model we demonstrate that inner ear organoids are capable of recapitulating genetic-associated phenotypes observed in vivo. Furthermore, with transgenic cell lines and scRNA-seq analyses, we revealed that cell membrane-bound TMPRSS3 is an essential component for HC homeostasis and survival. The scRNA-seq data from D35 inner ear organoids, which are equivalent to P12-P14 mouse inner ears, provided insight into HC development and the cellular roles of TMPRSS3. This study not only provides data on the role of TMPRSS3 in inner ear HCs, but it also highlights the utility of organoid systems as a powerful tool for understanding the genetic underpinnings of mammalian disease. 
EXPERIMENTAL PROCEDURES
Mouse Specimens
The care and use of animals were approved by the Indiana Univer- 
Derivation of mESCs
Derivation of mESCs from Tmprss3
WT and Tmprss3 Y260X mice followed the protocol of Czechanski et al. (2014) . See Supplemental Experimental Procedures for details.
Generation of the Tmprss3-KO ESC and 33FLAG-Tagged Tmprss3 Lines A Cas9n vector containing two guide RNAs (offset = 4 bp; Tmprss3_g1 and _g2; Table S5 ) targeting the adjacent region to the start codon of Tmprss3 was manufactured by DNA 2.0. The donor vector was assembled from a 2A-nGFP-PGK-Puro cassette, two $1-kb homology arms (LHA and RHA), and a pUC19 backbone using the Gibson Assembly master mix (New England Biolabs). The two homology arms were amplified from R1/E (ATCC SCRC-1036) genomic DNA (Tmprss3_LHA and Tmprss3_RHA; Table S5 ). The Cas9n vector and the donor vector were transfected into R1/ E mESCs following the manufacturer's protocol (P3 Primary Cell 4D-Nucleofector X kit, Lonza). The transfection was carried out in a 4D Nucleofector using the program CB-150. Cells then were maintained in modified LIF-2i medium (Table S6 ) (Choi et al., 2017) supplemented with 1 mM Scr7 (Xcessbio) for 48 h before puromycin selection as follows: medium containing 0.5 mg/mL puromycin was changed daily for 5 days before removing the PGK-Puro subcassette by transfecting a vector expressing Cre recombinase (Addgene #13775). Isolation of clonal cell lines followed a published protocol (Ran et al., 2013) . Successful insertion of the 2A-nGFP cassette was verified by PCR followed by DNA sequencing. 33FLAG-tagged Tmprss3 mESC was generated in similar procedures. See Supplemental Experimental Procedures for details.
Induction of Inner Ear Organoids
Induction followed the protocol of Koehler and Hashino (2014) , but with modifications ( Figure S7 ). In brief, ESCs were dissociated in Accutase (STEMCELL Technologies) and resuspended in differentiation medium (DMLK ; Table S6 ). On D0, 1,500 cells in 100 mL of DMLK per well were plated in low binding 96-well U-bottomed plates (Thermo Fisher). On D1, half of the medium was exchanged with fresh DMLK containing Matrigel (Corning; 2% final concentration). Bone morphogenetic protein 4 (PromoKine) and SB-431542 (Reprocell) were added on D3. Later, basic fibroblast growth factor (STEMCELL Technologies) and LDN-193189 (Reprocell) were added ( Figure S7 ). On D8, aggregates were washed twice in PBS before being transferred to new 96-well U-bottomed plates in 100 mL of N2 medium (Table S6) containing 1% Matrigel and 3 mM CHIR99021 (DeJonge et al., 2016) . After 48 h, aggregates were transferred to 24-well low binding plates in fresh N2 medium until D20. On D20, aggregates were cultured in organoid medium (Table S6 ) with constant shaking. Half of the medium was changed every other day during the long-term culture period.
scRNA-Seq of Inner Ear Organoids
Ten to twelve organoids were dissociated in TrypLE Express (Thermo Fisher) at 37 C with shaking for 40 min. During dissociation, samples were mixed with pipetting every 5-10 min. Dissociated cells were filtered through a 40-mm cell strainer (Flowmi) followed by three washes with Dulbecco's PBS + 2% BSA. Singlecell 3 0 RNA-seq experiments were conducted using the Chromium single-cell system (10x Genomics) and Illumina sequencers at the Center for Medical Genetics of Indiana University School of Medicine. See Supplemental Experimental Procedures for the scRNA-seq data process.
Analysis of scRNA-Seq Data
Integrated comparative analyses of two scRNA datasets were performed using Seurat 2.3 (Butler et al., 2018) . In brief, Seurat objects were set up and genes that were used in the analyses were chosen. Canonical correlation analyses (CCA) were carried out and alignments of CCA subspaces were performed to generate a new dimension reduction. Clusters for the new dimension reduction of integrated analyses were visualized using tSNE plots. Annotations of clusters ( Figures S5A-S5D ) were determined using top clusterdefining genes in addition to the data annotation based on mouse RNA-seq samples using the package singleR (Aran et al., 2018) . Average gene expressions were compared between samples (WT versus KO) within the same cluster. Scatterplots showed average gene expression comparisons, and genes enriched in samples were indicated. Gene ontology analyses were performed with annotation tools, Panther v14 (Mi et al., 2019) and STRING v11.0 (Gable et al., 2018) . Protein-protein interaction analysis was conducted using IntAct (https://www.ebi.ac.uk/intact/). Protein-protein interactions including at least three DEGs are presented in the main text. Gene over-representation tests, which examined whether biological processes and molecular features are enriched in the gene list of the HC cluster between samples, were carried out in Panther v14.
Microscopic Imaging and Statistical Analyses
See Supplemental Experimental Procedures for immunohistochemistry procedures. For assessment of the concentration of the apoptotic marker CASP3 in mouse vestibular sensory epithelia and C3H-derived otic vesicles, fluorescence intensity was measured (as gray values) from raw images using ImageJ software (NIH). For each vestibular sensory epithelium, gray values were averaged from three to four sections across the tissue. Six sensory epithelia for each vestibular organ type were included in the statistical analyses. Otic vesicles were identified based on the presence of HCs enclosed in the circular structure formed by SOX2 + cells ( Figure S3) . Gray values from three to five sections of one otic vesicle were averaged, and 14-16 otic vesicles from three independent experiments were included in statistical analyses. Onetailed t tests were carried out between WT and Tmprss3 mutant samples, and it was hypothesized that the latter would be characterized by higher CASP3 levels; an a level of 0.05 was set a priori.
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